Showing all 13 results
Altretamine Capsules
FreeAltretamine capsules are antineoplastic (chemotherapy) medications used primarily for the palliative treatment of advanced ovarian cancer. They are most commonly available in a 50 mg strength.
Cefepime & Tazobactam Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. The standard ratio is 8:1.
Strength Variant Cefepime Content Tazobactam Content Ratio 1.125 g Vial 1000 mg (1 g) 125 mg (Sodium) 8:1 (Standard) Excipients L-Arginine Buffer / Stabilizer – *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
Cefepime Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. It contains L-Arginine as a buffering agent (instead of sodium salts).
Active Ingredient Strength Therapeutic Role Cefepime Hydrochloride USP/BP Equivalent to 1000 mg (1 g) Cefepime Severe Infection / Sepsis Cefepime Hydrochloride USP/BP Equivalent to 500 mg Cefepime Pediatric / Moderate Infection Buffer L-Arginine pH Stabilizer (Approx 725 mg per g) *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
Cefpirome & Sulbactam Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. The standard ratio is 2:1.
Strength Variant Cefpirome Content (as Sulfate) Sulbactam Content (as Sodium) Ratio 1.5 g Vial 1000 mg (1 g) 500 mg 2:1 (Standard) Excipients Sodium Carbonate Buffer – *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
Cefpirome Sulfate Injection
FreeCefpirome sulfate injection is a fourth-generation cephalosporin antibiotic typically supplied as a sterile dry powder for intravenous (IV) or intramuscular (IM) administration
Metoclopramide Tablet
FreeProduct Composition & Packaging Specification
We supply Metoclopramide in the globally standardized therapeutic strength optimized for adult baseline three-times-daily dosage regimens.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Function Metoclopramide Hydrochloride USP / BP / IP 10 mg Oral Solid Uncoated Tablet (Scored for micro-dosing titration) The Prokinetic Driver: Accelerates upper gastrointestinal transit and blocks central emetic signals. Excipients Pharma Grade Lactose, Starch, Magnesium Stearate The Core Scaffold: High-solubility matrix engineered for rapid physical disintegration. Ondansetron Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Solution in glass ampoules or vials.
Active Ingredient Concentration Total Content & Format Ondansetron (as HCl Dihydrate) 2 mg / ml 4 mg in 2 ml Glass Ampoule Ondansetron (as HCl Dihydrate) 2 mg / ml 8 mg in 4 ml Glass Ampoule Excipients Citric Acid / Sodium Citrate pH Buffer System (pH 3.3 to 4.0) *Pack Sizes: Tray of 5/10 Ampoules or Box of 50 Ampoules.
Ondansetron Orally Disintegrating Tablets
FreeProduct Composition & Available Formats
We supply Ondansetron ODT in the two primary compendial configurations required to support initial introductory pediatric dosing up to high-potency surgical and oncological maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Delivery Matrix Primary Clinical Application Ondansetron Base / Hydrochloride USP / BP / IP 4 mg Fast-Dispersing Hydrophilic Matrix (ODT) Pediatric & General Antiemetic: First-line baseline dosing for acute gastroenteritis, pediatric oncology protocols, and mild post-operative nausea. Ondansetron Base / Hydrochloride USP / BP / IP 8 mg Fast-Dispersing Hydrophilic Matrix (ODT) High-Potency Emetic Control: Advanced strength engineered for highly emetogenic chemotherapy cycles, abdominal radiation protocols, and immediate post-surgical recovery fields. Oxaliplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Concentrate in glass vials. (Also available as Lyophilized Powder depending on market preference).
Active Ingredient Strength Volume Oxaliplatin USP/BP 5 mg / ml 10 ml Vial (Total 50 mg) Oxaliplatin USP/BP 5 mg / ml 20 ml Vial (Total 100 mg) Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Pemetrexed Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Light-Yellow Cake) in glass vials.
Active Ingredient Strength Reconstitution Pemetrexed Disodium 100 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 500 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 1000 mg (1 g) High-Dose Protocols Excipients Mannitol / Hydrochloric Acid / Sodium Hydroxide Bulking Agent / pH Adjusters (pH 6.6 – 7.8) *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Tamoxifen Citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg (Equivalent to Tamoxifen Base) Standard divided-dose therapy and specific prophylactic risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg (Equivalent to Tamoxifen Base) Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Tamoxifen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg Standard divided-dose therapy and specific risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Temozolomide Capsules
FreeTemozolomide capsules are oral chemotherapy agents used primarily to treat specific types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. Because temozolomide is a hazardous drug, the capsules are designed to be swallowed whole to prevent direct exposure to the potent active ingredient.
